
1. BMJ Open. 2021 Oct 28;11(10):e052101. doi: 10.1136/bmjopen-2021-052101.

BCG vaccination to reduce the impact of COVID-19 in healthcare workers: Protocol 
for a randomised controlled trial (BRACE trial).

Pittet LF, Messina NL, Gardiner K, Orsini F, Abruzzo V, Bannister S, Bonten M,
Campbell JL, Croda J, Dalcolmo M, Elia S, Germano S, Goodall C, Gwee A, Jamieson 
T, Jardim B, Kollmann TR, Guimarães Lacerda MV, Lee KJ, Legge D, Lucas M, Lynn
DJ, McDonald E, Manning L, Munns CF, Perrett KP, Prat Aymerich C, Richmond P,
Shann F, Sudbury E, Villanueva P, Wood NJ, Lieschke K, Subbarao K, Davidson A,
Curtis N; BRACE trial Consortium Group.

Collaborators: Abreu C, Abruzzo V, Addlem L, Agius S, Barbosa AA, Alamrousi A,
Santos AA, Al-Hindawi Y, Silveira SAD, Cruz LA, Anderson J, Anthony C, Pereira
AA, Almajano FA, Arnold A, Arrowsmith B, Azzopardi K, Marti CB, Bahaduri T,
Bannister S, Barney S, Barrera L, Barriocanal A, Barros D, Bartlett A, Muranaka
L, Baulman T, Bealing M, Beardsley J, Gutierrez AB, Bell J, Bennett-Wood V,
Bergant N, Barbosa FB, Bijllaardt W, Bimboese P, Andrade CB, Blauwendraat K,
Boersma W, Garcia PB, Bonnici R, Bonten M, Boon A, Bourke A, Bowes K, Brasil L,
Brophy C, Buchanan S, Bucholc J, Burns A, Burrell E, Bustos N, Byrne B, Byrne A, 
Calbo E, Montes JC, Camesella B, Campbell J, Cangas A, Carlin J, Roque MC, Diogo 
RC, Carvalho E, Casas I, Castro E, Castro R, Catterick H, Escobar RC, Chan J,
Cheah J, Chengodu T, Ciaverella M, Clark S, Espindola MC, Cobbledick A, Colaco C,
Collopy S, Comella P, Corbett M, Castro GC, Costa E, Coya R, Crawford N, Croda J,
Cruz A, Curtis N, Cushnahan J, Czajko A, Silva RD, Daitiri B, Dalcolmo M, Dalton 
K, Dao A, Davidson A, Dawe P, Dawson D, Costa MJ, Cruz K, Serna A, Batista FM,
Oliveira A, Morillo RDR, Desylva M, Dijkstra H, Dixon R, Lopez MD, Dominguez J,
Castellano AD, Santos GD, Lencina JS, Silva DS, Douglas M, Dunn R, Dunn A,
Dunnill J, Edmund H, Eiffler N, Elborough H, Elia S, Elkington O, England M,
Ayala WE, Esteve M, Evans N, Ewe K, Álvarez MC, Fahey K, Fairweather J, Faustman 
D, Silva EF, Fernandez M, Fidler G, Filius PMG, Finn A, Finucane C, Firth S,
Fletcher E, Flynn C, Flynn L, Fouracre L, Fowler S, Freitas T, Furtado AC,
Oliveira MG, Santos AG, Gonçalves LG, Galletta L, Gama L, Gamage D, Ganpat R,
Garcia M, García C, Croda MG, Gardiner K, Gardiner E, Gell G, Oliveira AG,
Germano S, Gibbons M, Gibson C, Gifford A, Poderos TG, Ginsberg A, Gisolf J,
Gladanac B, Glenn P, Godinho V, Santos MG, Goikoetxea J, Goldenberg T, Gomes A,
Marcos SG, Rico CG, Goodall C, Gordon V, Greven F, Capella AG, Guo C, Campos DG, 
Cuadra MG, Gwee A, Hall R, Hall L, Hamilton K, Hannan M, Harbech H, Harding A,
Haker N, Harrison R, Hassing RJ, Rosa TH, Haywood Z, Henare N, Andrade PH,
Herrmann S, Hill E, Hilton S, Huijbens D, Hutton H, Jamieson T, Janssen A, Jardim
B, Jardim T, Jarvis L, Jenkins N, Jones J, Jones J, Jones K, Jorge L, Vilegas MJ,
Joshi S, Joyce R, Junior J, Kandasamy R, Karunanayake A, Karuppasamy H, Keeble T,
Kent J, Kloeg P, Kluytmans J, Knight B, Kollmann T, Korman T, Krastev A, La N,
Lacerda M, Lacoma A, Lagunday R, Lalich D, Latkovic E, Latorre I, Junior PL, Lee 
K, Legge D, Lemmers T, Leurink T, Lieschke K, Lim K, Lockhart G, Bogéa CL, Santos
KL, Marques RL, Lucas M, Freitas ML, Ma N, Macalister S, Machado C, Ramos MM,
Machingaifa F, Maia I, Maia B, Malley R, Manning L, Manton S, Carrerero JM,
Barriocanal AM, Alves CM, Pereira RM, Arruda BM, Marins A, Martin C, Almeida KM, 
Mather W, Mathers M, Gomes FM, Tadokoro MM, Mazarakis N, Mazurega K, McAlister S,
McAndrews A, McDonald E, McDonald F, McElroy R, McMullan B, McPhate N, Mead L,
Meehan A, Meek B, Melo R, Mena G, Mesquita D, Messina N, Mezzetti I, Vieira HM,
Miller S, Mitchell K, Mitchell M, Mojeed J, Molenaar K, Molina G, Molina B,
Montgomery L, Moore C, Moore J, Moorlag S, Morawakage T, Moss J, Moyle W,
Mulholland K, Munns C, Nascimento E, Navarrette N, Netea M, Neves J, Newman G,
Ngien B, Nguyen J, Nguyen K, Noonan F, Norton W, O'Donnell M, O'Bryan J,
O'Connell A, Odoi S, O'Donnell L, Oliveira R, Oliveira M, Oliveira T, Oliveira I,
Olivier N, Olivio L, Ong B, Ong J, Ong J, Onysk J, Ooi I, Oppedisano F, Orsini F,
Ortika B, Group O, Otsuka A, Overton K, Owens R, Paes R, Palasanthiran P, Jiménez
VP, Pandine G, Parkin K, Hernandez AP, Paternotte N, Paterson D, Souza AP, Pelayo
L, Pell C, Pelser S, Pereira H, Pereira G, Perez G, Perez C, Porcuna TP, Perlen
S, Perrett K, Floy AP, Pitkin S, Pittet L, Pon RC, Calderón IP, Post J, Power C, 
Prado C, Prajitno E, Prat-Aymerich C, Preijers L, Puga M, Queiroz E, Quinn L, Rak
A, Figueiredo LR, Arellano ER, Ramos P, Oliveira KR, Ren J, Reynolds S, Rhodes S,
Santos CR, Richards C, Richmond P, Richmond H, Souza AR, Rocha J, Rodrigues T,
Rodrigues L, Rodrigues B, Fernandes IR, Rodríguez-Baño J, Roescher N, Rogers S,
Rol A, Romme J, Rosell A, Font MR, Sallent S, Sampaio V, Sanchez N, Sanchez B,
Santos D, Santos T, Sartim A, Sastry A, Sawka A, Schultz N, Seamark C, Seamark D,
Septer-Bijleveld E, Serrano R, Shann F, Sharma K, Shave M, Shen L, Sidaway-Lee K,
Baena AS, Silva R, Silva J, Silva E, Simão M, Singh R, Siqueira M, Chaves MS,
Sondag T, Sooriyarachchi E, Sousa A, Spry L, Statton S, Steer A, Santos DS,
Sterling K, Steve L, Stevens L, Stewart C, Stiglmayer L, Stooper L, Studham J,
Subbarao K, Sudbury E, Suiker A, Symons L, Taks E, Tan N, Meireles BT, Riele MT, 
Oever JT, Lima GT, Heine RT, Angelo JT, Thomson H, Toh R, Trindade A, Tripp H,
Tristán E, Troeman D, Truelove A, Tsuha D, Uffing M, Val F, Valero O, Valls E,
Ven CV, Heuvel LV, Veen SV, Waal MV, van Leusen JH, Mook LV, van Onzenoort H,
Opdorp MV, Rijen MV, Sluis NV, Vasconcelos A, Vega N, Velagapudi S, Vennells L,
Venton T, Verheij H, Verhoeven PM, Ramos CV, Silva PV, Vidal S, Vieira P,
Oliveira MV, Ortega RV, Villanueva P, Villar R, Vlahos A, Wadia U, Wall K,
Wallace R, Waring J, Warren R, Warris A, Watts E, Wearing-Smith M, Webber-Rookes 
D, Wedderburn J, Wee-Hee A, Teo JW, Whale B, Williams P, Wolters B, Wood N, Xie
I, Younes A, Young A, Batista FZ, Zhou C, Zwart V.

INTRODUCTION: BCG vaccination modulates immune responses to unrelated pathogens. 
This off-target effect could reduce the impact of emerging pathogens. As a
readily available, inexpensive intervention that has a well-established safety
profile, BCG is a good candidate for protecting healthcare workers (HCWs) and
other vulnerable groups against COVID-19.
METHODS AND ANALYSIS: This international multicentre phase III randomised
controlled trial aims to determine if BCG vaccination reduces the incidence of
symptomatic and severe COVID-19 at 6 months (co-primary outcomes) compared with
no BCG vaccination. We plan to randomise 10 078 HCWs from Australia, The
Netherlands, Spain, the UK and Brazil in a 1:1 ratio to BCG vaccination or no BCG
(control group). The participants will be followed for 1 year with questionnaires
and collection of blood samples. For any episode of illness, clinical details
will be collected daily, and the participant will be tested for SARS-CoV-2
infection. The secondary objectives are to determine if BCG vaccination reduces
the rate, incidence, and severity of any febrile or respiratory illness
(including SARS-CoV-2), as well as work absenteeism. The safety of BCG
vaccination in HCWs will also be evaluated. Immunological analyses will assess
changes in the immune system following vaccination, and identify factors
associated with susceptibility to or protection against SARS-CoV-2 and other
infections.
ETHICS AND DISSEMINATION: Ethical and governance approval will be obtained from
participating sites. Results will be published in peer-reviewed open-access
journals. The final cleaned and locked database will be deposited in a data
sharing repository archiving system.
TRIAL REGISTRATION: ClinicalTrials.gov NCT04327206.

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published 
by BMJ.

DOI: 10.1136/bmjopen-2021-052101 
PMCID: PMC8557250
PMID: 34711598  [Indexed for MEDLINE]

Conflict of interest statement: Competing interests: None declared.

